|
|
|
|
|
|
Hubei HONCH Pharmaceutical Co.,Ltd is located at the beautiful and the well-known medical sage hometown -Li Shizhen Pharmaceutical industry park, devoting to Research & Development, production and sale of the newest anti-tumor medicine and new pharmaceutical material (intermediate). The company occupies 20,000 square meters, with 2,000 square meters of GMP standard production workshop.we own several sets of imported high-performance and sensitive liquid chromatography, gas chromatography and ultraviolet spectrophotometer analytic instruments etc. which carry on the effective analysis and the monitoring to the products.
At present, we mainly produce Vinorelbine Tartrate,Docetaxel, Vinorelbine,
Paclitaxel and Vinblastine Sulfate pharmaceutical material etc. our company has first-class technology and equipments as well as the sound quality management system. Vinorelbine Bitartrate has fully met the latest USP31,EP5.4 standard.
We own Strong technical force, with a large number of experienced senior staff, high-level R & D team, first-class laboratory equipments and good research atmosphere, which ensure the strength of research and development of our products always stand in the first-class. We have maintained close cooperation with many research institutes which makes the quality and speed of developing and producing new products always in advanced position both domestic and overseas.
We hold "serve for people's health, improve life quality, achieve customer value, realize self-beyond" corporate philosophy. We sincerely hope to cooperate with medical enterprise and research and development organization worldwide in such competitive time. |
|
|
| pharmaceutical raw material, Pharmaceutical intermediate, anti-tumor, Vinorelbine Tartrate, API, APIs, Docetaxel, Vinorelbine, Vinblastine Sulfate, Paclitaxel |
|
|
| Company : |
Hubei HONCH Pharmaceutical Co.,Ltd(Wuhan) |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
